Andersons pediatric cardiology 2030
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.69 KB, 3 trang )
2003;42:1982–1987.
7.GatzoulisMA,BeghettiM,GalieN,etal.
Longer-termbosentantherapyimproves
functionalcapacityinEisenmengersyndrome:
resultsoftheBREATHE-5open-labelextension
study.IntJCardiol.2008;127:27–32.
8.MukhopadhyayS,SharmaM,RamakrishnanS,
etal.Phosphodiesterase-5inhibitorin
Eisenmengersyndrome:apreliminary
observationalstudy.Circulation.
2006;114:1807–1810.
9.VizzaCD,SciomerS,MorelliS,etal.Long
termtreatmentofpulmonaryarterial
hypertensionwithberaprost,anoralprostacyclin
analogue.Heart.2001;86:661–665.
10.RosenzweigEB,KersteinD,BarstRJ.Long-term
prostacyclinforpulmonaryhypertensionwith
associatedcongenitalheartdefects.Circulation.
1999;99:1858–1865.
11.SandovalJ,AguirreJS,PulidoT,etal.Nocturnal
oxygentherapyinpatientswiththeEisenmenger
syndrome.AmJRespirCritCareMed.
2001;164:1682–1687.
12.SandovalJ,AlvaradoP,Martinez-GuerraML,et
al.Effectofbodypositionchangeson
pulmonarygasexchangeinEisenmenger's
syndrome.AmJRespirCritCareMed.
1999;159(4Pt1):1070–1073.
13.ChauEMC,FanKYY,ChowWH.Effectsof
chronicsildenafilinpatientswithEisenmenger
syndromeversusidiopathicpulmonaryarterial
hypertension.IntJCardiol.2007;120(3):301–
305.
14.GalièN,BeghettiM,GatzoulisMA,etal.
BosentantherapyinpatientswithEisenmenger
syndrome:amulticenter,double-blind,
randomized,placebo-controlledstudy.
Circulation.2006;114(1):48–54.
15.SchmaltzAA,NeudorfU,WinklerUH.Outcome
ofpregnancyinwomenwithcongenitalheart
disease.CardiolYoung.1999;9:88–96.
16.LoRitoM,GazzazT,WilderTJ,etal.
Pulmonaryveinstenosis:severityandlocation
predictsurvivalaftersurgicalrepair.JThorac
CardiovascSurg.2016;151(3):657–666e2.
17.MahgoubL,KaddouraT,KamenyAR,etal.
Pulmonaryveinstenosisofex-prematureinfants
withpulmonaryhypertensionand
bronchopulmonarydysplasia,epidemiology,and
survivalfromamulticentercohort.Pediatr
Pulmonol.2017;52(8):1063–1070.
18.CallahanR,KieranMW,BairdCW,etal.
Adjuncttargetedbiologicinhibitionagentsto
treataggressivemultivesselintraluminal
pediatricpulmonaryveinstenosis.JPediatr.
2018.
19.HenaineR,VergnatM,BachaEA,etal.Effects
oflackofpulsatilityonpulmonaryendothelial
functionintheFontancirculation.JThorac
CardiovascSurg.2013;146(3):522–529.
20.RestrepoM,MirabellaL,TangE,etal.Fontan
pathwaygrowth:aquantitativeevaluationof
lateraltunnelandextracardiaccavopulmonary
connectionsusingserialcardiacmagnetic
resonance.AnnThoracSurg.2014;97(3):916–
922.
21.HebertA,MikkelsenU,ThilenU,etal.Bosentan
improvesexercisecapacityinadolescentsand
adultsaftertheFontanoperation:theTEMPO
(treatmentwithendothelinreceptorantagonistin
Fontanpatients,arandomized,placebocontrolled,double-blindstudymeasuringpeak
oxygenconsumption)study.Circulation.
2014;130(3):2021–2030.
22.GoldbergDJ,FrenchB,McBrideMG,etal.
Impactoforalsildenafilonexercise
performanceinchildrenandyoungadultsafter
theFontanoperation:arandomized,doubleblind,placebo-controlled,crossovertrial.
Circulation.2011;123(11):1185–1193.
23.AbmanSH,HansmannG,ArcherSL,etal.
